Mr. Pat Mellon:

If AI is going to be a huge benefit and learning tool for everybody in the development of healthcare and practical implications, it should not all just go to the industry.

If AI is going to be used then it, and alternatives, should be available to the people who need the healthcare. The danger is that some of the big pharmaceutical companies or the big medical companies will get the information and use it for their benefit. It also has to work the other way so people are given alternatives.